Here, CTCs were defined as positive for either pan-keratins for breast cancer and NSCLC or PMEL17/Melan-A-positive for melanoma samples, positive nucleus signal (DAPI) and negative for CD45 (leukocyte exclusion marker). Here, PTPRC is linked to breast carcinoma.